Trial reportBMC anesthesiology2026
Combined intrathecal fentanyl and morphine for postoperative analgesia after total knee arthroplasty: a randomised controlled trial.
Trial report in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03365115 (Influence of Combined Intrathecal Morphine and Fentanyl in Patients Undergoing Total Knee Arthroplasty), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Influence of Combined Intrathecal Morphine and Fentanyl in Patients Undergoing Total Knee Arthroplasty
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundTotal knee arthroplasty (TKA) is associated with significant postoperative pain. This study aimed to evaluate whether the combined intrathecal administration of morphine and fentanyl improves postoperative analgesia compared with either agent alone.
methodsIn this randomised controlled trial, 111 patients undergoing TKA under spinal anaesthesia were assigned to receive intrathecal fentanyl 25 µg (F group), morphine 100 µg (M group), or a combination of fentanyl 25 µg and morphine 100 µg (MF group). All groups received 12.5 mg of 0.5% hyperbaric bupivacaine. The primary outcome was the resting pain score at 6 h postoperatively. Secondary outcomes included pain scores (at rest and during movement) at 12 and 24 h, cumulative 24-h opioid consumption, opioid-related adverse effects, and intraoperative haemodynamic variables.
resultsAt 6 h, resting pain scores were significantly lower in the MF group than in the F and M groups (1.5 ± 0.9 vs. 4.2 ± 2.7 and 2.7 ± 2.0; P < 0.001). Pain scores at rest and during motion at 6, 12, and 24 h were consistently lower in the MF group (P < 0.001). Cumulative 24-h morphine consumption was reduced in the MF group (10 ± 7 mg) compared with the F (30 ± 16 mg) and M (15 ± 9 mg) groups (P < 0.001). Nausea and vomiting were more frequent in the M and MF groups than in the F group, with no significant difference between the M and MF group.
conclusionsCombined intrathecal administration of morphine and fentanyl provided superior postoperative analgesia and reduced opioid consumption compared with either agent alone, without increasing opioid-related adverse effects compared with morphine alone. This strategy represents a viable analgesic option, particularly when peripheral nerve blocks are not feasible.
trial registrationClinicalTrials.gov (NCT03365115; Date of registration: 30/11/2017).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.